Evelo Biosciences Stock Price Prediction
| EVLO Stock | USD 0.0005 0.00 0.00% |
Momentum 18
Sell Peaked
Oversold | Overbought |
Using Evelo Biosciences hype-based prediction, you can estimate the value of Evelo Biosciences from the perspective of Evelo Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evelo Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Evelo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Evelo Biosciences after-hype prediction price | USD 5.69E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Evelo |
Evelo Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Evelo Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evelo Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Evelo Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evelo Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Evelo Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evelo Biosciences' historical news coverage. Evelo Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 50.03, respectively. We have considered Evelo Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evelo Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Evelo Biosciences is based on 3 months time horizon.
Evelo Biosciences Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Evelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evelo Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evelo Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
6.21 | 55.93 | 0.07 | 0.16 | 1 Events / Month | 4 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0005 | 0.0006 | 13.87 |
|
Evelo Biosciences Hype Timeline
Evelo Biosciences is currently traded for 0.0005. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of -0.16. Evelo is expected to increase in value after the next headline, with the price projected to jump to 5.69E-4 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is estimated to be 13.87%, whereas the daily expected return is currently at 6.21%. The volatility of related hype on Evelo Biosciences is about 216447.37%, with the expected price after the next announcement by competition of -0.16. Evelo Biosciences currently holds 51.14 M in liabilities with Debt to Equity (D/E) ratio of 1.55, which is about average as compared to similar companies. Evelo Biosciences has a current ratio of 4.44, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Evelo Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Evelo Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Evelo Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Evelo to invest in growth at high rates of return. When we think about Evelo Biosciences' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next expected press release will be very soon. Check out Evelo Biosciences Basic Forecasting Models to cross-verify your projections.Evelo Biosciences Related Hype Analysis
Having access to credible news sources related to Evelo Biosciences' direct competition is more important than ever and may enhance your ability to predict Evelo Biosciences' future price movements. Getting to know how Evelo Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evelo Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INFIQ | Infinity Pharmaceuticals | 0.00 | 8 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LIFS | Life Stem Genetics | (0.0001) | 17 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 | |
| ARDS | Aridis Pharmaceuticals | (0.0001) | 16 per month | 35.56 | 0.34 | 1,000.00 | (90.91) | 1,141 | |
| STAB | Statera Biopharma | 0.00 | 0 per month | 19.28 | 0.20 | 100.00 | (50.00) | 266.67 | |
| TRVN | Trevena | (0.01) | 7 per month | 0.00 | 0 | 0.00 | 0.00 | 106.67 | |
| ICCT | iCoreConnect Common stock | 0.00 | 0 per month | 34.09 | 0.21 | 233.33 | (72.73) | 540.00 | |
| HSTC | HST Global | (0.25) | 10 per month | 0.00 | 0.18 | 0.00 | 0.00 | 4,954 | |
| PXMD | PaxMedica Common Stock | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 4,998 | |
| BTAX | Biostax Corp | (0.0002) | 6 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SECI | Sector 10 | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Evelo Biosciences Additional Predictive Modules
Most predictive techniques to examine Evelo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evelo using various technical indicators. When you analyze Evelo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Evelo Biosciences Predictive Indicators
The successful prediction of Evelo Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evelo Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evelo Biosciences based on analysis of Evelo Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evelo Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evelo Biosciences's related companies.
Story Coverage note for Evelo Biosciences
The number of cover stories for Evelo Biosciences depends on current market conditions and Evelo Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Evelo Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Evelo Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Evelo Biosciences Short Properties
Evelo Biosciences' future price predictability will typically decrease when Evelo Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Evelo Biosciences often depends not only on the future outlook of the potential Evelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.4 M | |
| Cash And Short Term Investments | 47.9 M |
Other Information on Investing in Evelo Pink Sheet
Evelo Biosciences financial ratios help investors to determine whether Evelo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evelo with respect to the benefits of owning Evelo Biosciences security.